Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00505453
Status:
COMPLETED
Last Update Posted:
2016-11-04
First Post:
2007-07-20
Brief Title:
A Phase III Open-Label Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral Vaccine
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-20
First Submit QC Date:
July 20 2007
Study First Post Date:
2007-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-03
Last Update Post Date:
2016-11-04
Last Update Post Date Type:
ESTIMATED